Additional probiotic therapy lowers SCORAD index in children with atopic dermatitis

Main Article Content

Jessica Ekaputri
Rita Evalina
Melda Deliana


Atopic dermatitis (AD) is a common skin disease that is usually chronic, relapsing, causing pruritus and frequent in children. The pathogenesis of AD involves genetic, immunological and environmental factors causing skin barrier dysfunction and dysregulation of the immune system. Probiotic treatment has been claimed to offer several functional properties including stimulation of the immune system and plays an important role in AD. The objective of this study was to evaluate the effect of probiotic therapy on atopic dermatitis in children.

A randomized controlled trial was conducted on 62 children suffering from AD from December 2015 to January 2016. AD severity was assessed based on the scoring of atopic dermatitis (SCORAD) index. Subjects were divided into two groups consisting of 32 and 30 children, the probiotic (probiotic + emollient) and control (emollient) groups, respectively. SCORAD index was re-evaluated after 2 weeks of therapy. The data was analyzed using Mann Whitney test.

After the intervention, the mean SCORAD index in the probiotic group was significantly much lower than the control group (18.09 ± 8.59 vs 23.21 ± 8.71; p=0.001). The mean decrease in SCORAD index in the probiotic group was 40.4 %, much higher than the control group 25.2%. The number needed to treat (NNT) score of probiotic treatment was 5.3.

The addition of probiotics to conventional therapy effectively lowers SCORAD index by 40.4% in atopic dermatitis. The impact of probiotics on SCORAD indices is thought to be attained by modification of the immunogenicity of potential allergens.

Article Details

How to Cite
Ekaputri, J., Evalina, R., & Deliana, M. (2016). Additional probiotic therapy lowers SCORAD index in children with atopic dermatitis. Universa Medicina, 35(2), 68–74.
Original Articles


Bieber T. Atopic dermatitis. N Engl J Med 2008;358:1483-94.

Watson W, Kapur S. Atopic dermatitis. Allergy Asthma Clin Immunol 2011;7(Suppl 1):S4.

Beck LA. Atopic dermatitis. In: Lichtenstein LM, Busse WW, Geha RS, editors. Current therapy in allergy, immunology, and rheumatology. 6th edition. Philadelphia: Elsevier;2004. p.88-92.

DaVeiga SP. Epidemiology of atopic dermatitis: a review. Allergy Asthma Proc 2012;33:227-34.

Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/ American Academy of Allergy, Asthma and Immunology/ PRACTALL Consensus Report. Allergy 2006; 61:969-87.

Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: Section 1 Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol 2014; 70:338-51.

Charman C, Chambers C, Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? J Invest Dermatol 2003;120:932–41.

Darsow U, Wollenberg A, Simon D, et al. Difficult to control atopic dermatitis. WAO J 2013;6:6.

Rubel D, Thirumoorthy T, Soebaryo RW, et al. Consensus guidelines for the management of atopic dermatitis: an Asia-Pacific perspective. J Dermatol 2013; 40:160-71.

Thomas DW, Greer FR. Committee on nutrition: section on Gastroenterology, Hepatology and Nutrition. Clinical report: Probiotics and prebiotics in pediatrics. Pediatrics 2010;126: 1217-31.

Fiocchi A, Burks W, Bahna SL, et al. Clinical use of probiotics in pediatric allergy (CUPPA): a World Allergy Organization position paper. WAOJ 2012;5:148-67.

Elazab N, Mendy A, Gasana J, et al. Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials. Pediatrics 2013; 132:e666-e76.

Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, et al. Probiotics for the treatment of eczema: a systematic review. Clin Exp Allergy 2009;39: 1117-27.

Gore C, Custovic A, Tannock GW, et al. Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: Randomized controlled trial with follow-up until age 3 years. Clin Exp Allergy 2012;42:112-22.

Prescott SL, Bjorksten B. Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol 2007;120:255-62.

Madiyono B, Moechlisan S, Sastroasmoro S, et al. Perkiraan besar sampel. In: Sastroasmoro S, Ismael S, editors. Dasar-dasar metodologi penelitian klinis. 4th edition. Jakarta: Sagung Seto;2011.p.348-381.

Yesilova Y, Calka O, Akdeniz N, et al. Effect of probiotic on the treatment of children with atopic dermatitis. Ann Dermatol 2012;24:189-93.

Yao TC, Chang CJ, Hsu YH, et al. Probiotics for allergic disease: realities and myths. Pediatr Allergy Immunol 2010;21:900-19.

Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008;121:116-21.

Michail SK, Stolfi A, Johnson T, et al. Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials. Am Allergy Asthma Immunol 2008;101:508-16.

Ogden NS, Bielory L. Probiotics: a complementary approach in the treatment and prevention of pediatric atopic disease. Curr Opin Allergy Clin Immunol 2005;5:179-84.

Winkler P, Ghadimi D, Scherezenmeir J, et al. Molecular and cellular basis of microflora-host interactions. J Nutr 2007;137:766S-72S.

Sekhon BS, Jairath S. Prebiotics, probiotics and synbiotics: an overview. J Pharm Educ Res 2010; 1:13-30.

Kaur IP, Kuhad A, Garg A, et al. Probiotics: potential pharmaceutical applications. In: Cho SS, Finocchiaro ET, editors. Handbook of prebiotics and probiotics ingredients. Florida: CRC Press;2010.p.381-408.

Pan SJ, Kuo CH, Lam KP, et al. Probiotics and allergy in children: an update review. Pediatr Allergy Immunol 2010;21:e659-e66.